Year All2024202320222021202020192018201720162015201420132012201120102007 04.18.12 Syndax Pharmaceuticals Appoints Arlene Morris as CEO Read More 04.09.12 Syndax Pharmaceuticals Announces Start of Phase 1/2 Study of Entinostat in Combination with Lapatinib in HER2-Positive Metastatic Breast Cancer Read More 04.05.12 Syndax Pharmaceuticals Appoints Arthur M. Pappas to Board of Directors Read More 03.29.12 Syndax Pharmaceuticals to Present at Upcoming Conferences Read More 02.08.12 Syndax Pharmaceuticals Announces Entinostat Enhanced Activity of Cancer Immunotherapies in Renal and Prostate Cancer Models Read More 02.07.12 Syndax Pharmaceuticals to Present at Upcoming Conferences Read More 01.05.12 Syndax Pharmaceuticals Signs Agreement with Ventana Medical Systems, Inc. to Develop Companion Diagnostic Test for Entinostat Read More 12.20.11 ENGAGE 501 Poster Presented by Dr. Anas Younes at ASH 2011 Read More 12.11.11 Entinostat Demonstrates Activity in Hodgkin's Lymphoma Read More 12.07.11 Survival Benefit With Syndax Pharmaceuticals' Entinostat Maintained in Women with Advanced Breast Cancer Read More 12.07.11 ENCORE 301 Poster Presented by Dr. Denise Yardley at SABCS Read More 12.01.11 Multiple Data Presentations on Syndax Pharmaceutical's Entinostat at Upcoming Scientific Conferences Read More
04.09.12 Syndax Pharmaceuticals Announces Start of Phase 1/2 Study of Entinostat in Combination with Lapatinib in HER2-Positive Metastatic Breast Cancer Read More
02.08.12 Syndax Pharmaceuticals Announces Entinostat Enhanced Activity of Cancer Immunotherapies in Renal and Prostate Cancer Models Read More
01.05.12 Syndax Pharmaceuticals Signs Agreement with Ventana Medical Systems, Inc. to Develop Companion Diagnostic Test for Entinostat Read More
12.07.11 Survival Benefit With Syndax Pharmaceuticals' Entinostat Maintained in Women with Advanced Breast Cancer Read More
12.01.11 Multiple Data Presentations on Syndax Pharmaceutical's Entinostat at Upcoming Scientific Conferences Read More